ArticleHuman gene therapy2012

AAV-mediated gene targeting is significantly enhanced by transient inhibition of nonhomologous end joining or the proteasome in vivo.

Nicole K Paulk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.